Lumexa Imaging (NASDAQ:LMRI) Stock Price Up 10.6% – What’s Next?

Lumexa Imaging Holdings, Inc. (NASDAQ:LMRI)’s stock price rose 10.6% on Monday . The stock traded as high as $15.78 and last traded at $15.64. Approximately 382,727 shares changed hands during trading, a decline of 37% from the average daily volume of 607,072 shares. The stock had previously closed at $14.14.

Analyst Ratings Changes

Separately, Raymond James Financial raised shares of Lumexa Imaging from an “outperform” rating to a “strong-buy” rating and set a $23.00 price objective on the stock in a research report on Monday, February 9th. One research analyst has rated the stock with a Strong Buy rating, Based on data from MarketBeat.com, the company has an average rating of “Strong Buy” and a consensus price target of $23.00.

Lumexa Imaging Stock Up 0.3%

Institutional Investors Weigh In On Lumexa Imaging

Several institutional investors and hedge funds have recently added to or reduced their stakes in LMRI. Assetmark Inc. bought a new position in Lumexa Imaging in the fourth quarter valued at about $36,000. Barclays PLC purchased a new stake in shares of Lumexa Imaging during the 4th quarter valued at about $133,000. Sandia Investment Management LP bought a new position in shares of Lumexa Imaging in the 4th quarter worth approximately $185,000. Hudson Bay Capital Management LP purchased a new position in shares of Lumexa Imaging in the fourth quarter worth approximately $237,000. Finally, Oxford Asset Management LLP purchased a new position in shares of Lumexa Imaging during the 4th quarter worth $670,000.

Lumexa Imaging Company Profile

We are one of the largest national providers of diagnostic imaging services(1). Our platform is integrated, scalable and has a proven track record of creating value for our stakeholders. As of September 30, 2025, we and our affiliates operated the second largest(1) outpatient imaging center footprint in the United States. It spans 184 centers(2)across 13 states and includes eight joint venture partnerships with health systems. Our centers are in attractive metropolitan statistical areas (“MSAs”).